Report for Froestl W

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (4)

Title : Increased Efflux of Amyloid-beta Peptides through the Blood-Brain Barrier by Muscarinic Acetylcholine Receptor Inhibition Reduces Pathological Phenotypes in Mouse Models of Brain Amyloidosis - Paganetti_2014_J.Alzheimers.Dis_38_767
Author(s) : Paganetti P , Antoniello K , Devraj K , Toni N , Kieran D , Madani R , Pihlgren M , Adolfsson O , Froestl W , Schrattenholz A , Liebner S , Havas D , Windisch M , Cirrito JR , Pfeifer A , Muhs A
Ref : J Alzheimers Dis , 38 :767 , 2014
Abstract : Paganetti_2014_J.Alzheimers.Dis_38_767
ESTHER : Paganetti_2014_J.Alzheimers.Dis_38_767
PubMedSearch : Paganetti_2014_J.Alzheimers.Dis_38_767
PubMedID: 24072071

Title : Poster: GABAB receptor positive modulators: Effects on nicotine self-administration and cue-induced reinstatement of nicotine-seeking behavior in rats -
Author(s) : Vlachou S , Guery S , Froestl W , Kaupmann K , Banerjee D , Finn MG , Markou A
Ref : Biochemical Pharmacology , 78 :917 , 2009
PubMedID:

Title : Prolonged nicotine exposure does not alter GABA(B) receptor-mediated regulation of brain reward function - Paterson_2005_Neuropharmacol_49_953
Author(s) : Paterson NE , Bruijnzeel AW , Kenny PJ , Wright CD , Froestl W , Markou A
Ref : Neuropharmacology , 49 :953 , 2005
Abstract : Paterson_2005_Neuropharmacol_49_953
ESTHER : Paterson_2005_Neuropharmacol_49_953
PubMedSearch : Paterson_2005_Neuropharmacol_49_953
PubMedID: 16005474

Title : Repeated administration of the GABAB receptor agonist CGP44532 decreased nicotine self-administration, and acute administration decreased cue-induced reinstatement of nicotine-seeking in rats - Paterson_2005_Neuropsychopharmacology_30_119
Author(s) : Paterson NE , Froestl W , Markou A
Ref : Neuropsychopharmacology , 30 :119 , 2005
Abstract : Paterson_2005_Neuropsychopharmacology_30_119
ESTHER : Paterson_2005_Neuropsychopharmacology_30_119
PubMedSearch : Paterson_2005_Neuropsychopharmacology_30_119
PubMedID: 15266350